Pro-Dex Stock
Pro-Dex, Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Country
- United States
- CEO
- Richard Lee Van Kirk Jr.
- Employees
- 204
- Market cap
- $188 M
- IPO
- 07/08/1986
Pro-Dex, Inc. focuses on the development and manufacturing of advanced motorized surgical instruments. These sophisticated tools are supplied globally to original equipment manufacturers (OEMs) in the medical device sector. Their product portfolio features versatile, autoclavable (sterilization-friendly) surgical…
Pro-Dex stock: price history
1D
-2.9%
1W
-6.8%
1M
-18.9%
6M
+9.1%
YTD
+51.4%
1Y
+143.7%
2Y
+105.5%
5Y
+126.6%
10Y
+1,180.4%
Next earnings date
Next earnings date
29/10/2026 (in 12 days)
Volatility around earnings
~59% stronger price swings than usual
Ask the agents about Pro-Dex
Analyst assessment of Pro-Dex
0
STRONG BUY
1
BUY
0
HOLD
0
SELL
0
STRONG SELL
1
TOTAL · Buy
As of: 11/09/2026
Pro-Dex stock metrics
P/E
13.81
P/B
3.95
EV/EBITDA
9.94
RETURN ON EQUITY
6.0%
NET MARGIN
14.0%
DEBT/EQUITY
0.38
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
54.5%
FLOAT SHARES
1,762,570
AVG. DAILY VOLUME (30D)
68,333
Insider transactions (SEC)
Van Kirk Richard Lee Jr
Van Kirk Richard Lee Jr
Van Kirk Richard Lee Jr
Van Kirk Richard Lee Jr
Van Kirk Richard Lee Jr
Institutional holders
Dividends & Stock splits
Comparable stocks
Frequently asked questions about Pro-Dex stock
What does Pro-Dex do?
Pro-Dex, Inc. is a company in the Healthcare sector, Medical - Instruments & Supplies industry, headquartered in United States.
The CEO is Richard Lee Van Kirk Jr., the company employs around 204 people.
The IPO was on 07/08/1986; the stock trades on NASDAQ under the ticker PDEX.
What do analysts say about Pro-Dex stock?
1 analysts rate the stock, the consensus is Buy (as of 11/09/2026).
This is an external assessment, not a statement by Market Jury.
When does Pro-Dex report next?
The next earnings date is 29/10/2026.
Around past earnings, price swings were roughly 59% stronger than usual.
Does Pro-Dex pay a dividend?
No, Pro-Dex currently does not pay a dividend.
Which stocks are comparable to Pro-Dex?
Comparable stocks include Intuitive Surgical, Becton, Dickinson and Company, ResMed, West Pharmaceutical Services, Solventum, Baxter International, Cooper Companies and Avantor.
How can I get Pro-Dex stock analyzed?
Clicking "Analyze stock" lets five strategies assess Pro-Dex against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.